HUDSON, N.Y., Aug. 23, 2017 -- Taconic Biosciences announces plans to move its corporate headquarters up the Hudson River from Hudson to the Albany, NY area at the end of 2017. The new location is near several existing Taconic facilities in Rensselaer, 45 miles from its primary operations facility in Germantown, NY, and accessible to all global locations.
With Taconic’s increasing prominence within the global pharmaceutical industry, the location of the new headquarters will provide a more convenient venue for key stakeholders and customers, provide access to highly-skilled talent, and puts Taconic in the center of the booming Albany technology hub. The new facility will house the company’s leadership team, as well as members of its product strategy, marketing, human resources, finance, quality, customer service, and business technology teams. 35 jobs will relocate to the Albany area, while 28 will move to the Germantown facility. “Relocating Taconic’s headquarters to the Health Sciences Campus expands on a long-standing relationship between the two organizations. The resulting co-location of more than 130 Taconic employees will increase internal collaboration across functions. The site’s easily accessible location to highly educated talent, as well as proximity to prospective partners and customers, makes it an ideal fit,” shared David Lester, senior vice president of human resources and organization development.
Located on the Albany Health Sciences Campus in Rensselaer, NY, the new corporate headquarters will be in the state-of-the-art Cancer Research Center building, which already houses Taconic’s molecular analysis laboratory. The site is home to other key players within the pharmaceutical industry, notably Regeneron, Albany Molecular Research, Inc., Albany Medical College, Albany College of Pharmacy, and several other biomedical organizations. Taconic also occupies two other buildings on the campus, housing its scientific services business and operations functions. “We are pleased to expand our relationship with Taconic and bring additional jobs to the UABDC property,” expressed Richard P. McGinn Jr, executive director at the University at Albany Bioscience Development Corporation.
The address of the Cancer Research Center building on the Albany Health Campus is:
1 Discovery Drive
Rensselaer, NY 12144
With over six decades of animal model experience, Taconic Biosciences leveraged its strong roots in the Hudson Valley to build an international organization that is recognized as a global leader in in biomedical research.
To learn more about Taconic Biosciences, please call 1-888-TACONIC (888-822-6642) in the US, or +45 70 23 04 05 in Europe, or email [email protected].
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Media Contact: Kelly Owen Grover Director of Marketing Communications (518) 697-3824


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



